Alan W. Partin MD, PhD

Biographical Sketch:

Alan W. Partin, MD, PhD, is the author or co-author of more than 600 scientific articles, serves on numerous editorial boards, served as editor-in-chief of Urology (1997–2007), and is currently an editor of the Campbell-Walsh-Wein urology text. He has been honored with many awards, including the Hopkins Young Investigators Award, the Pfizer Scholars in Urology award, and the Gold Cystoscope award. In 2004, Dr. Partin was named Director of the Department of Urology at the Brady Urological Institute and, in 2005, Urologist-in-Chief of the Johns Hopkins Hospital.

Dr. Partin is an expert in assessing prognosis and making predictions for men with prostate cancer. Dr. Partin’s laboratories and clinical and surgical interests focus on developing and testing new and existing methods for predicting the aggressiveness of prostate cancers so that rational treatment decisions can be made by both patients and physicians.

Dr. Partin received his undergraduate degree in chemistry from the University of Mississippi, where he was an Academic All-American football player. He received his medical degree and his PhD in pharmacology and molecular sciences from Johns Hopkins University, where he continued his post-doctoral training.

Positions:
Director, Department of Urology, Brady Urological Institute; Urologist-in-Chief, Johns Hopkins Hospital

Degrees:
PhD (pharmacology and molecular sciences): Johns Hopkins University
MD: Johns Hopkins University School of Medicine

Clinical Interests:
Developing and testing methods for predicting the aggressiveness of prostate cancers